| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | procollagen 1 N-terminal peptide,P1NP, procollagen I N-terminal peptide,PINP |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | serum, plasma, tissue homogenates |
| Sensitivity | |
| Species | |
| Target |
Background
procollagen Ⅰ N-terminal peptide (PⅠNP) is a biological molecule commonly studied in others research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.
Biological context
Researchers often monitor procollagen Ⅰ N-terminal peptide in serum, plasma, and tissue homogenates to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in procollagen Ⅰ N-terminal peptide may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, procollagen Ⅰ N-terminal peptide may also appear under names such as procollagen 1 N-terminal peptide,P1NP, and procollagen I N-terminal peptide,PINP. When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that procollagen Ⅰ N-terminal peptide participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
RKIP regulates bone marrow macrophage differentiation to mediate osteoclastogenesis and H-type vessel formation
Z Zheng, S Tao, J Jin, Y Li, L Dai, Z Huang,Nature Communications,2025
Testosterone Delays Bone Microstructural Destruction via Osteoblast‐Androgen Receptor‐Mediated Upregulation of Tenascin‐C
Y Xie, M Pan, Z Zhang, L Zhang, H Liu,Advanced Science,2025
Stephanine Protects Against Osteoporosis by Suppressing Osteoclastogenesis via Inhibition of the RANKL—RANK Interaction
T Liu, J Li, M Duan, Y Wang, Z Jiang,Journal of Cellular and Molecular Medicine,2024
Altered post-fracture systemic bone loss in a mouse model of osteocyte dysfunction
B Osipov, AJ Emami, HC Cunningham, S Orr,JBMR plus,2024
FOXO1-mTOR pathway in vascular pericyte regulates the formation of type H vessels to control bone metabolism
C Cheng, M Deng, C Cheng, H Wu, Y Wang,Journal of Orthopaedic Translation,2024
Hybrid complex of tyrosinase and carbon-based materials for tissue engineering applications
고중현,서울대학교 대학원,2024
Single-Walled Carbon Nanotube-Guided Topical Skin Delivery of Tyrosinase to Prevent Photoinduced Damage
J Ko,ACS nano,2023
FNDC5/irisin ameliorates bone loss of type 1 diabetes by suppressing endoplasmic reticulum stressmediated ferroptosis
Q Dong,Journal of orthopaedic surgery and research,2024
Activation of TAZ by XMU-MP-1 inhibits osteoclastogenesis and attenuates ovariectomy-induced cancellous bone loss
X Li,Biochemical and biophysical research communications,2023
Icariin, a phytoestrogen, exerts rapid estrogenic actions through crosstalk of estrogen receptors in osteoblasts
KY Wong,Phytotherapy research,2023
Bone-targeting engineered small extracellular vesicles carrying anti-miR-6359-CGGGAGC prevent valproic acid-induced bone loss
M Ghoneum,Signal transduction and targeted therapy,2024
Cervical vertebrae for early bone loss evaluation in osteoporosis mouse models
B Teng,Quantitative imaging in medicine and surgery,2023
Identification and characterization of NFATc1+ skeletal stem cells in bone regeneration
F Yu,Cell reports,2022
Peptide modified geniposidic acid targets bone and effectively promotes osteogenesis
M Liu,Journal of Orthopaedic Translation,2022
Asiatic acid improves high-fat-diet-induced osteoporosis in mice via regulating SIRT1/FOXO1 signaling and inhibiting oxidative stress
X Chen,Histology and histopathology,2022
SIS3 suppresses osteoclastogenesis and ameliorates bone loss in ovariectomized mice by modulating Nox4-dependent reactive oxygen species
Wenzheng Pan,Biochemical pharmacology,2021
Conditional Knockout of PDK1 in Osteoclasts Suppressed Osteoclastogenesis and Ameliorated Prostate Cancer-Induced Osteolysis
Y Zhang,Researchsquare,2021
Mutations in Profilin 1 cause early-onset Paget's disease of bone with giant cell tumors
Z Wei,Journal of Bone and Mineral Research,2021
Conditional knockout of the PDK‐1 gene in osteoblasts affects osteoblast differentiation and bone formation
Y Bai,Journal of Cellular Physiology,2021
Acanthopanax senticosus aqueous extract ameliorates ovariectomy-induced bone loss in middle-aged mice by inhibiting the receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis
H Xu,Food & Function,2020
Deficiency of PDK1 in osteoclasts delays fracture healing and repair
D Xiao,Molecular Medicine Reports,2020
Hydrogen sulfide protects against particle‐induced inflammatory response and osteolysis via SIRT1 pathway in prosthesis loosening
Liu L,FASEB,2020
The emerging role of IMD 0354 on bone homeostasis by suppressing osteoclastogenesis and bone resorption, but without affecting bone formation
Chen W, et al,Cell Death and Disease,2019
A novel transgenic murine model with persistently brittle bones simulating osteogenesis imperfecta type I
Yi Liu, et al,Bone,2019
Malt1 deficient mice develop osteoporosis independent of osteoclast-intrinsic effects of Malt1 deficiency
Monajemi M, et al,Journal of Leukocyte Biology,2019
A novel anti-osteoporotic agent that protects against postmenopausal bone loss by regulating bone formation and bone resorption
Yu-te Yang .et al,Life Sciences,2018
A Novel Diterpenoid Suppresses Osteoclastogenesis and Promotes Osteogenesis by Inhibiting Ifrd1-and IkBa-Mediated p65 Nuclear Translocation
/,Journal of Bone and Mineral Research ,2017
Effect of alendronate on post-traumatic osteoarthritis induced by anterior cruciate ligament rupture in mice
Khorasani MS.et al,Arthritis Res Ther.,2015
Altered bone development in a mouse model of peripheral sensory nerve inactivation.
Heffner MA et al,J Musculoskelet Neuronal Interact,2014